SRS271 - The impact of PCSK9 inhibitors on carotid intima-media thickness and the association with lipid parameters: a systematic review, meta-analysis and meta-regression

View at publisher Summarise with VIRAT
Authors: Vangelis Bontinis, Daniel Curley, Jona Musai, Eva Karlöf, Efstatios Georgakarakos, Sarah Onida, Alun Huw Davies, Joseph Shalhoub
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Objective We assessed impact of PCSK9 inhibitors (PCSK9i) on carotid intima-media thickness (cIMT) and their interplay with lipid profile parameters. Methods Systematic review conducted in accordance with PRISMA guidelines. Primary endpoint was cIMT reduction (millimetres). Meta-regression examined influence of demographic, imaging, and biochemical parameters on cIMT. Heterogeneity exploration was conducted via leave-one-out and Baujat plot analyses. Results Four randomized controlled trials comparing PCSK9i plus statin versus placebo plus statin, and two single-arm studies were included, enrolling 607 patients and 2175 carotid segments. Pooled analysis demonstrated significant reduction in cIMT; mean difference (MD) −0.03 (95%c.i.: −0.05 to −0.01) (I2 = 95.4%, P < 0.01). Following exploration and mitigation of heterogeneity, this reduction persisted; MD −0.01 (95%c.i.: −0.02 to −0.01) (I2 = 0%, P = 0.59). Initially, comparison between PCSK9i and placebo yielded non-significant cIMT reduction favouring PCSK9i; MD −0.04 (95%c.i.: −0.10 to 0.03) (I² = 98.6%, P < 0.01). Following heterogeneity adjustment, effect estimate reached statistical significance, demonstrating consistent cIMT reduction with PCSK9i; MD −0.01 (95%c.i.: −0.02 to −0.01) (I² = 52%, P = 0.12). Meta-regression displayed associations between baseline cIMT (β = −0.45, P < 0.01), HDL (β = 1.92, P < 0.01) and cIMT. Pooled between-group cIMT differences showed moderate correlations with the respective differences in total (r = 0.69) and LDL cholesterol (r = 0.59). Conclusions Evidence supports potential association between PCSK9i treatment and cIMT reduction, with observed correlations involving total and LDL cholesterol indicating lipid-mediated vascular response. These findings warrant cautious interpretation given substantial heterogeneity, partly driven by baseline differences in cIMT and lipid profiles. Future studies should ensure baseline comparability in vascular and biochemical parameters to strengthen causal inferences.

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Cardiovascular Health and Disease Prevention Atherosclerosis and Cardiovascular Diseases

Publication details

Journal / source
British journal of surgery
Volume
113
Issue
Supplement_2
Publication date
1 March 2026
Language
EN